
ABOUT US
AboutUs
AboutUs
Nanjing leading Medical Technology Co., Ltd., established in 2019, is a service provider that provides integrated solutions of raw materials and reagents for brand customers. Product categories cover high-end antigens, antibodies, enzymes, nano-microspheres, and multi-disease package OEM reagents, and can provide customized raw materials/reagent development, contract manufacturing, and contract registration services according to customer needs. Based on its core competence in reagent development, Lido Medical has established technical platforms for biochemistry and immunology, specific proteins, POCT chromatography, and ELISA, and has developed upstream raw materials and downstream product production services around reagent development, orderly extending product lines and technical routes, and building a product matrix that responds to centralized procurement needs.
-
6000
+ /M2R&D Headquarters Supporting P2 Biological Laboratory
-
500
+ /The cooperative enterprise's products have received widespread acclaim both domestically and internationally.
-
10000
+ /M2A large-scale biochemical and immunology CDMO platform in China
PRODUCT
Products Center
Products Center




Let every life receive more accurate diagnosis and treatment
One-stop "Product" Integrated Solution
Reagent Development Platform + Protein Raw Material Platform + Nano-microsphere Platform
Diagnostic Standard for Diabetes

Let every life receive more accurate diagnosis and treatment
One-stop "Product" Integrated Solution
Reagent Development Platform + Protein Raw Material Development Platform + Nano-microsphere Development Platform
One of the most sensitive indicators of inflammation

Let every life receive more accurate diagnosis and treatment
One-stop "Product" Integrated Solution
Reagent Development Platform + Protein Raw Material Development Platform + Nano-microsphere Development Platform
Key indicator for deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC)
NEWS CENTER
News News
NewsNews